Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 393.0	$ 415.8
Accounts receivable, less allowance for credit losses	1,446.4	1,442.4
Inventories	2,388.2	2,385.2
Prepaid expenses and other current assets	403.8	366.1
Total Current Assets	4,631.5	4,609.5
Property, plant and equipment, net	2,090.9	2,060.4
Goodwill	8,791.5	8,818.5
Intangible assets, net	4,734.1	4,856.4
Other assets	1,204.4	1,152.1
Total Assets	21,452.4	21,496.9
Current Liabilities:
Accounts payable	370.3	410.6
Income taxes payable	70.3	61.2
Other current liabilities	1,386.3	1,485.7
Current portion of long-term debt	970.0	900.0
Total Current Liabilities	2,797.0	2,857.4
Deferred income taxes, net	370.4	357.6
Long-term income tax payable	275.8	273.7
Other long-term liabilities	577.0	652.1
Long-term debt	4,826.2	4,867.9
Total Liabilities	8,846.4	9,008.7
Commitments and Contingencies (Note 15)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 317.2 million shares as of March 31, 2024 (316.2 million as of December 31, 2023) issued	3.2	3.2
Paid-in capital	9,945.9	9,846.1
Retained earnings	10,509.0	10,384.5
Accumulated other comprehensive loss	(211.2)	(191.0)
Treasury stock, 111.5 million shares as of March 31, 2024 (110.6 million as of December 31, 2023)	(7,648.9)	(7,562.3)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,598.0	12,480.5
Noncontrolling interest	8.1	7.7
Total Stockholders' Equity	12,606.0	12,488.1
Total Liabilities and Stockholders' Equity	$ 21,452.4	$ 21,496.9